LAPSE:2023.2765
Published Article
LAPSE:2023.2765
Insights into the Impact of Rosmarinic Acid on CHO Cell Culture Improvement through Transcriptomics Analysis
Zhuangrong Huang, Jianlin Xu, Jun Tian, Kathryn L. Aron, Yueming Qian, Michael C. Borys, Zhengjian Li, Girish Pendse
February 21, 2023
Abstract
The use of antioxidants in Chinese hamster ovary (CHO) cell cultures to improve monoclonal antibody production has been a topic of great interest. Nevertheless, the antioxidants do not have consistent benefits of production improvement, which might be cell line specific and/or process specific. In this work, we investigated how treatment with the antioxidant rosmarinic acid (RA) improved cell growth and titer in CHO cell cultures using transcriptomics. In particular, transcriptomics analysis indicated that RA treatment modified gene expression and strongly affected the MAPK and PI3K/Akt signaling pathways, which regulate cell survival and cell death. Moreover, it was observed that these signaling pathways, which had been identified to be up-regulated on day 2 and day 6 by RA, were also up-regulated over time (from initial growth phase day 2 to slow growth or protein production phase day 6) in both conditions. In summary, this transcriptomics analysis provides insights into the role of the antioxidant RA in industrial cell culture processes. The current study also represents an example in the industry of how omics can be applied to gain an in-depth understanding of CHO cell biology and to identify critical pathways that can contribute to cell culture process improvement and cell line engineering.
Keywords
antibody titer improvement, antioxidants, CHO cell, pathway analysis, rosmarinic acid, transcriptomics
Suggested Citation
Huang Z, Xu J, Tian J, Aron KL, Qian Y, Borys MC, Li Z, Pendse G. Insights into the Impact of Rosmarinic Acid on CHO Cell Culture Improvement through Transcriptomics Analysis. (2023). LAPSE:2023.2765
Author Affiliations
Huang Z: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA [ORCID]
Xu J: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA [ORCID]
Tian J: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA
Aron KL: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA
Qian Y: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA
Borys MC: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA
Li Z: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA [ORCID]
Pendse G: Biologics Development, Global Product Development and Supply, Bristol Myers Squibb, Devens, MA 01434, USA
Journal Name
Processes
Volume
10
Issue
3
First Page
533
Year
2022
Publication Date
2022-03-08
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr10030533, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2023.2765
This Record
External Link

https://doi.org/10.3390/pr10030533
Publisher Version
Download
Files
Feb 21, 2023
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
197
Version History
[v1] (Original Submission)
Feb 21, 2023
 
Verified by curator on
Feb 21, 2023
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2023.2765
 
Record Owner
Auto Uploader for LAPSE
Links to Related Works
Directly Related to This Work
Publisher Version